Johns Hopkins Psychiatry Guide
Guanfacine
INDICATIONS
FDA
FDA
- Attention deficit hyperactivity disorder (ADHD) in pediatric patients (> 6 years old), as monotherapy or adjunctive therapy with stimulants
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 30, 2025
Citation
Weinstein, Sujin L. "Guanfacine." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787441/all/Guanfacine.
Weinstein SL. Guanfacine. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787441/all/Guanfacine. Accessed October 8, 2025.
Weinstein, S. L. (2025). Guanfacine. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787441/all/Guanfacine
Weinstein SL. Guanfacine [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787441/all/Guanfacine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Guanfacine
ID - 787441
A1 - Weinstein,Sujin,PharmD, BCPP
Y1 - 2025/08/30/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787441/all/Guanfacine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
